Cargando…
Engineering Grp170-based immune modulators for cancer immunotherapy
We have recently demonstrated that glucose-regulated protein 170 (Grp170), a stress-responsive molecular chaperone of the endoplasmic reticulum, can be exploited to stimulate anticancer immunity due to its superior antigen chaperoning and delivering capacity. The immune remodeling of the tumor micro...
Autores principales: | Yu, Xiaofei, Wang, Xiang-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716734/ https://www.ncbi.nlm.nih.gov/pubmed/23894699 http://dx.doi.org/10.4161/onci.24385 |
Ejemplares similares
-
Antagonizing the innate pattern recognition receptor CD204 to improve dendritic cell-targeted cancer immunotherapy
por: Yu, Xiaofei, et al.
Publicado: (2012) -
Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies
por: Abate-Daga, Daniel, et al.
Publicado: (2014) -
The Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer Therapeutics
por: Wang, Hongxia, et al.
Publicado: (2015) -
The immune landscape of human tumors: Implications for cancer immunotherapy
por: Bindea, Gabriela, et al.
Publicado: (2014) -
A novel strategy for modulation of MDSC to enhance cancer immunotherapy
por: Ghansah, Tomar
Publicado: (2012)